ClinicalTrials.govpublic full text
Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy
breast cancer, tyrosine kinase inhibitors, lapatinib, biologic response modifiers, magnetic resonance imaging, treatment-naive, operable, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.